SEngine Precision Medicine brings the latest advances in cancer research and treatment to the fight against cancer. With a focus on functional screening, genomics, robotics, cancer organoid cultures, and bioinformatics, SEngine Precision Medicine is providing invaluable data to oncologists and realizing the promise of precise, less toxic and more effective therapies to cancer patients. The accumulation of data is essential to pharmaceutical companies to accelerate the success of cancer treatments.
SEngine is CLIA certified to receive your sample today.
Location: United States, Washington, Seattle
Employees: 11-50
Total raised: $24.1M
Founded date: 2015
Founders name: Lonnie Bookbinder, MBA, PhD
Investors 1
| Date | Name | Website |
| - | WRF Capita... | wrfseattle... |
Funding Rounds 2
| Date | Series | Amount | Investors |
| 10.08.2022 | Series A | $19M | - |
| 03.10.2019 | Series A | $5.1M | - |
Mentions in press and media 14
| Date | Title | Description | Source |
| 18.04.2023 | Protein design to precision health: Vote for Health Innovati... | Finalists for the 2023 GeekWire Health Innovation of the Year. This year’s nominees for the Health ... | geekwire.c... |
| 10.08.2022 | Fred Hutch spinout lands $10M for precision test to guide ca... | SEngine CEO and chief scientific officer Carla Grandori. (SEngine Photo) Seattle startup SEngine Pr... | geekwire.c... |
| 28.07.2022 | SEngine Precision Medicine closes Series A bringing total fi... | SEATTLE, July 28, 2022 (GLOBE NEWSWIRE) -- Seattle-based Precision Oncology company SEngine Precisio... | globenewsw... |
| 09.07.2021 | Biotech startup using AI to take guesswork out of cancer dru... | From the moment cancer is diagnosed, the clock starts ticking. Early treatment can lead to better ou... | medcitynew... |
| 14.08.2020 | Canada’s Atomwise secures 163M CAD in Series B funding | The AI-driven drug discovery platform was founded in 2012 by Abraham Heifets, Alexander Levy and Dr.... | vcbay.news... |
| 02.10.2019 | SEngine Precision Medicine Raises $5.1M in Series A Funding | SEngine Precision Medicine, a Seattle, Wash.-based oncology company, closed a $5.1m in Series A fund... | finsmes.co... |
| 02.10.2019 | Fred Hutch spinout SEngine raises $5.1M to test cancer treat... | SEngine tests how safe and effective various cancer drugs are against a patient’s tumor. Each well i... | geekwire.c... |
| 03.06.2019 | What’s health tech’s evolving role in cancer treatment? Lear... | Through a mix of provocative conversations, interactive networking, and a showcase of the hottest st... | medcitynew... |
| 09.05.2019 | Don’t miss this innovation in cancer treatment conference in... | A panel discussion will explore how precision medicine can be the key to population health. Experts ... | medcitynew... |
| 29.10.2018 | SEngine Precision Medicine raises $3M, adds former Fred Hutc... | A SEngine Precision Medicine employee in the company’s lab. (SEngine Precision Medicine Photo) SEng... | geekwire.c... |
Show more